ATE378602T1 - Quantifizierung von botulinum toxin - Google Patents
Quantifizierung von botulinum toxinInfo
- Publication number
- ATE378602T1 ATE378602T1 AT04713111T AT04713111T ATE378602T1 AT E378602 T1 ATE378602 T1 AT E378602T1 AT 04713111 T AT04713111 T AT 04713111T AT 04713111 T AT04713111 T AT 04713111T AT E378602 T1 ATE378602 T1 AT E378602T1
- Authority
- AT
- Austria
- Prior art keywords
- quantification
- botulinum toxin
- botulinum
- toxin
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/944—Acetylcholine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0303997A GB2398636A (en) | 2003-02-21 | 2003-02-21 | Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378602T1 true ATE378602T1 (de) | 2007-11-15 |
Family
ID=9953431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04713111T ATE378602T1 (de) | 2003-02-21 | 2004-02-20 | Quantifizierung von botulinum toxin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8877456B2 (de) |
| EP (1) | EP1597584B1 (de) |
| JP (2) | JP2006518211A (de) |
| KR (1) | KR101161879B1 (de) |
| CN (1) | CN100401069C (de) |
| AR (1) | AR043254A1 (de) |
| AT (1) | ATE378602T1 (de) |
| AU (1) | AU2004213639B2 (de) |
| CA (1) | CA2516377A1 (de) |
| DE (1) | DE602004010073T2 (de) |
| GB (1) | GB2398636A (de) |
| NZ (1) | NZ541853A (de) |
| PL (1) | PL377994A1 (de) |
| RU (1) | RU2350961C2 (de) |
| WO (1) | WO2004074838A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE032950T2 (en) | 2004-08-04 | 2017-11-28 | Ipsen Biopharm Ltd | Pharmaceutical preparation containing botulinum neurotoxin A2 |
| GB2416849A (en) * | 2004-08-04 | 2006-02-08 | Ipsen Ltd | Method for determining the quantity of a pre-synaptic neuromuscular blocking substance in a sample |
| WO2006013370A1 (en) | 2004-08-04 | 2006-02-09 | Ipsen Limited | Pharmaceutical composition containing botulinum neurotoxin a2 |
| US7473559B2 (en) * | 2006-04-05 | 2009-01-06 | Charles Lee | Method for measuring the content of a botulinum toxin in a formulation |
| EP2202518A1 (de) | 2008-12-19 | 2010-06-30 | Merz Pharma GmbH & Co.KGaA | In-Vivo-Assay zur Quantifizierung der clostridiellen Neurotoxinaktivität |
| WO2011060916A1 (en) | 2009-11-18 | 2011-05-26 | Merz Pharma Gmbh & Co. Kgaa | Assay for quantifying clostridial neurotoxin |
| RU2616281C2 (ru) | 2011-09-29 | 2017-04-13 | СЕЛЛСНЭП, ЭлЭлСи | Композиции и способы испытаний на токсикогенность |
| CN105339790B (zh) | 2013-06-28 | 2018-04-17 | 莫茨制药有限及两合公司 | 用于确定神经毒素多肽在细胞中的生物活性的工具和方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5251621A (en) * | 1991-12-18 | 1993-10-12 | Telectronics Pacing Systems, Inc. | Arrhythmia control pacer using skeletal muscle cardiac graft stimulation |
| US5631373A (en) | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| US5591217A (en) * | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
| SE9603841D0 (sv) * | 1996-10-18 | 1996-10-18 | Pacesetter Ab | A tissue stimulating apparatus |
| ES2256945T5 (es) * | 1997-07-15 | 2010-03-26 | The Regents Of The University Of Colorado | Uso de terapia de neurotoxinas para el tratamiento de trastornos de la prostata. |
-
2003
- 2003-02-21 GB GB0303997A patent/GB2398636A/en not_active Withdrawn
-
2004
- 2004-02-20 KR KR1020057015360A patent/KR101161879B1/ko not_active IP Right Cessation
- 2004-02-20 CN CNB2004800046866A patent/CN100401069C/zh not_active Expired - Fee Related
- 2004-02-20 DE DE602004010073T patent/DE602004010073T2/de not_active Expired - Lifetime
- 2004-02-20 AT AT04713111T patent/ATE378602T1/de not_active IP Right Cessation
- 2004-02-20 NZ NZ541853A patent/NZ541853A/en not_active IP Right Cessation
- 2004-02-20 AR ARP040100547A patent/AR043254A1/es active IP Right Grant
- 2004-02-20 US US10/545,009 patent/US8877456B2/en not_active Expired - Fee Related
- 2004-02-20 CA CA002516377A patent/CA2516377A1/en not_active Abandoned
- 2004-02-20 RU RU2005129338/15A patent/RU2350961C2/ru not_active IP Right Cessation
- 2004-02-20 EP EP04713111A patent/EP1597584B1/de not_active Revoked
- 2004-02-20 AU AU2004213639A patent/AU2004213639B2/en not_active Ceased
- 2004-02-20 WO PCT/GB2004/000697 patent/WO2004074838A1/en active IP Right Grant
- 2004-02-20 PL PL377994A patent/PL377994A1/pl not_active Application Discontinuation
- 2004-02-20 JP JP2006502311A patent/JP2006518211A/ja not_active Withdrawn
-
2011
- 2011-07-21 JP JP2011160053A patent/JP2011254825A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2350961C2 (ru) | 2009-03-27 |
| PL377994A1 (pl) | 2006-02-20 |
| NZ541853A (en) | 2007-02-23 |
| AU2004213639B2 (en) | 2010-04-29 |
| CN100401069C (zh) | 2008-07-09 |
| AR043254A1 (es) | 2005-07-20 |
| GB2398636A (en) | 2004-08-25 |
| CN1751238A (zh) | 2006-03-22 |
| CA2516377A1 (en) | 2004-09-02 |
| KR20050113184A (ko) | 2005-12-01 |
| US8877456B2 (en) | 2014-11-04 |
| GB0303997D0 (en) | 2003-03-26 |
| JP2006518211A (ja) | 2006-08-10 |
| US20060263352A1 (en) | 2006-11-23 |
| JP2011254825A (ja) | 2011-12-22 |
| DE602004010073T2 (de) | 2008-09-11 |
| RU2005129338A (ru) | 2006-06-10 |
| DE602004010073D1 (de) | 2007-12-27 |
| EP1597584B1 (de) | 2007-11-14 |
| WO2004074838A1 (en) | 2004-09-02 |
| KR101161879B1 (ko) | 2012-07-05 |
| EP1597584A1 (de) | 2005-11-23 |
| AU2004213639A1 (en) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60321324D1 (de) | Sulfonylaminoderivate als neue inhibitoren von histondeacetylase | |
| DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
| ATE525377T1 (de) | Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase | |
| DE50304983D1 (de) | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren | |
| DE60330694D1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
| DK1599504T3 (da) | Modificeret antistof | |
| ATE358667T1 (de) | Pyridin-derivate als matrix metalloproteinase inhibitoren | |
| NO20055459D0 (no) | Prosesser | |
| DE602005019971D1 (de) | Inhibitoren von cysteinprotease | |
| DE602004027504D1 (de) | Aminobenzophenonverbindungen | |
| DE60320776D1 (de) | Magnetisches niederprofilelement | |
| DE60324208D1 (de) | Biarylsulfonamide als mmp-inhibitoren | |
| DE602004013990D1 (de) | Ernen von spänen | |
| DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
| DE502004006055D1 (de) | 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren | |
| ATE402700T1 (de) | Glycinamid-derivate als raf-kinase-hemmer | |
| DE602004032525D1 (de) | Rstellungsverfahren dafür | |
| DE602004018858D1 (de) | Emulsionszusammensetzung | |
| ATE378602T1 (de) | Quantifizierung von botulinum toxin | |
| DE602004026773D1 (de) | Verfahrensherstellung von ethern | |
| IS6884A (is) | Aðferðir við að nýta líffræðilegan fjölbreytileika | |
| DE602004021365D1 (de) | Substituierte phenylacetamide und ihre anwendung als protease inhibitoren | |
| DE502004004348D1 (de) | Hydraulischer Funktionsblock | |
| NO20035626D0 (no) | Metode | |
| DE502004008985D1 (de) | Sichere erfassung von eingabewerten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |